AI Is Reinventing Medicine. Antifragile Florida Physicians Will Win (2026)

A radiologist in Tampa reads her last study of the night. The AI flagged it before she opened the image, a pulmonary nodule the size of a peppercorn tucked into a corner of the lower lobe she might have reached at 6 a.m. on her second coffee. The software did not replace her. It changed what her attention was worth.

That single shift in worth is the whole story, and most of the noise about AI in medicine misses it. The question physicians keep being asked is whether the machine will take the job. The better question is what happens to the value of a doctor’s mind once the routine parts of thinking get automated away. Florida physicians who answer that second question well are going to come out of this decade stronger than they went in. The ones who keep arguing about the first question are going to get repriced without a say in it.

The Disruption Is Real

Peter Diamandis laid out the scope in his essay “5 Ways AI Is Reinventing Health.” When ChatGPT passed the U.S. Medical Licensing Exam in early 2023, it stopped being a curiosity and became a forecast. The companies he profiles are not pitching decks. PathAI’s pathology models improved diagnostic accuracy by 20% and cut errors by 25% against traditional reads. Aidoc’s FDA-cleared radiology platform reduces time to diagnosis by up to 50% with a 95% sensitivity rate on flagged findings. Color Health’s cancer copilot, built with OpenAI, let clinicians work through a patient’s records in five minutes. Insilico Medicine designs drug candidates with 50 people where legacy pharma uses 5,000. Intuitive’s da Vinci system has now assisted more than 10 million procedures.

The most telling data point is the one closest to a Florida reading room. In a Swedish study of 80,000 women, a single radiologist working with AI caught 20% more cancers than two radiologists working without it, while the technology cut human workload by 44%. One doctor plus a machine outperformed two doctors. Read that again, because the implication for a profession running short on bodies is the entire argument.

Bertalan Mesko, the physician behind The Medical Futurist, has spent a decade pushing back on the replacement panic. The Silicon Valley investor Vinod Khosla once predicted technology would replace 80% of doctors. Mesko disagrees, and his reasoning is the clinical one: medicine is not a linear process where an input yields a guaranteed output, and the tasks worth protecting are the ones that need creativity, judgment, and empathy. His line is worth keeping: technologies are “not meant to replace what physicians do,” he writes, but to contribute to their work. The machine takes the repetitive and the monotonous. What it leaves behind is the part that was always the actual practice of medicine.

Antifragility in the Neuroeconomy

Here is the frame I keep coming back to, borrowed from Nassim Taleb. A fragile system breaks under stress. A resilient system resists it and stays the same. An antifragile system gains from it, growing stronger precisely because it was stressed. Most of the conversation about AI treats the goal as mere resilience, as physicians bracing to survive the disruption intact. That is the wrong target. The opportunity is to be antifragile, to use the disruption as the thing that makes the profession more valuable.

This is where the Neuroeconomy comes in. Think of cognition as a market. When a kind of mental work becomes cheap and abundant, its price falls. When it stays scarce, its price climbs. AI is about to flood the market with one specific category of cognition: pattern detection, documentation, retrieval, the structured recall that medical training has historically rewarded and exhausted physicians to provide. As that category gets demonetized, the cognition AI cannot supply appreciates. Judgment under genuine uncertainty. Moral reasoning at the bedside. The relationship that makes a frightened patient trust a plan. Knowing which rule to break and when.

AI does not delete the physician’s value. It reprices it, and the repricing favors exactly the human capacities that burnout and documentation have been crowding out. The antifragile physician reads that repricing early and moves her cognitive capital toward where it is becoming scarce. She lets the software absorb the charting and the first-pass read, and reinvests the reclaimed hours into the parts of medicine that do not commoditize. The disruption is the stressor. The growth is the point.

What the Workforce Numbers Actually Say

The labor math makes this less a philosophy than a necessity. The Association of American Medical Colleges projects a shortage of up to 86,000 physicians by 2036, with primary care alone short by 20,200 to 40,400 and surgical specialties by 10,100 to 19,900. That deficit is baked in. We cannot train our way out of it on the timeline the demand curve demands.

Meanwhile the people we have are stretched thin. The American Medical Association put the 2025 physician burnout rate at 41.9%, down from 48.2% in 2023 but still capturing four in ten doctors, and emergency medicine tops the list at 49.8%. The administrative load is one of the largest drivers, and this is the seam where AI does its most honest work. Among physicians already using AI, 68% increased their use of it for clinical documentation over the past year. Among small-practice clinicians who adopted these tools, 69% report less administrative burden, 52% work fewer after-hours, and 57% report better patient care. A 2025 randomized trial preprint found that an AI scribe reduced burnout, work exhaustion, and overall task load.

Put the two facts together. A workforce running a structural deficit cannot afford to spend trained physician cognition on tasks a machine does faster. The fragile reading of AI says it eliminates doctors. The antifragile reading says it is the only mechanism by which a shrinking workforce does more of what only doctors can do. Florida, with its aging population and its physician distribution problems, sits at the sharp end of that math.

What Florida Physicians Should Do Now

1. Audit where your cognition actually goes. Time-track one ordinary week and mark every hour spent on work a current tool can already handle: documentation, prior-authorization letters, inbox triage, chart summarization. Those hours are your reclaimable capital, and you cannot reinvest what you have not measured.

2. Pilot one tool, but put the consent guardrails in place first. Our earlier coverage of the AI scribe consent litigation in Florida showed how fast ambient documentation collides with Florida’s two-party consent statute when vendors move ahead of counsel. Bring your attorney in before the vendor demo, not after.

3. Position your specialty toward the judgment-heavy edge. Mesko’s analysis names radiology, pathology, oncology, and surgery as fields where the technology arrives first and hardest. In each, the value migrates from volume reads toward complex cases, integration, and the calls the model cannot make, so move with it deliberately.

4. Insist that physicians lead the deployment. The difference between AI that relieves burnout and AI that deepens it is who chooses the metric it optimizes. If administrators and payers select the tools, they will optimize throughput. Engage the Florida Medical Association and demand a clinician seat at every procurement table. Then go further and join The Atlas Accord, the physician-led alliance organizing the collective voice that keeps doctors at the front of decisions like these rather than on the receiving end of them.

5. Build the cognitive capital that appreciates. Diagnostic reasoning, communication, and leadership are the assets the Neuroeconomy is about to reward. Invest in them the way you once invested in memorizing the things a machine will now remember for you.

The Self-Augmentation Question

Now the edge of the map. Everything above keeps the physician and the machine as separate agents. The transhumanist proposition erases the gap and puts the interface inside the skull.

This is no longer speculative. Neuralink has implanted its device in more than a dozen participants with paralysis and ALS, letting them control computers by thought, and in May 2025 secured an FDA Breakthrough Device Designation for speech restoration. Its CONVOY study has a participant operating an assistive robotic arm. Synchron’s Stentrode, threaded through a blood vessel rather than implanted in open brain surgery, now lets users drive an iPhone and an Apple Vision Pro directly from neural signals, and the company has moved into pivotal trials. Analysts put limited commercial availability somewhere around 2028 to 2030.

Every one of those uses is restorative, giving back what disease or injury took. The transhumanist question is the next one: augmentation of the already healthy. A physician choosing a brain-computer interface not to recover a lost function but to read the record faster, hold more in working memory, or query a model without a screen. If human cognition is the appreciating asset in the Neuroeconomy, some physicians will ask whether to upgrade the asset directly.

So I want to hear from you. If a safe, reversible brain-computer interface could augment your clinical cognition, would you implant one? Reply to this post and tell me yes, no, or not until the data is in. I will share where Florida’s physicians land in a future issue. The technology is coming whether or not we have an opinion ready. I would rather we form ours first.

Frequently Asked Questions

Will AI replace Florida physicians?

No credible evidence points that way. The stronger pattern is augmentation: AI absorbs documentation, pattern detection, and routine reads, while judgment, complex decision-making, and the patient relationship stay with the physician. A Swedish study found one radiologist working with AI outperformed two without it, which matters most in a workforce facing a projected shortage of up to 86,000 physicians by 2036.

What does “antifragility in the Neuroeconomy” mean for doctors?

Antifragility describes a system that gains from stress rather than merely surviving it. In a cognitive economy, when AI makes routine mental work cheap, the human cognition it cannot replicate becomes scarce and more valuable. Physicians who shift their effort toward judgment, moral reasoning, and patient relationships are repriced upward by the same disruption that threatens those who do not.

How can AI reduce physician burnout in Florida practices?

Administrative load is a leading driver of burnout, which the AMA measured at 41.9% nationally in 2025. Among small-practice clinicians using AI tools, 69% report less administrative burden, 52% work fewer after-hours, and 57% report better patient care, and a 2025 randomized trial found AI scribes reduced burnout and task load. The relief is real when physicians, not administrators, choose the tools.

Are brain-computer interfaces being used in medicine yet?

Yes, in restorative applications. Neuralink has implanted devices in more than a dozen participants with paralysis and ALS and holds an FDA Breakthrough Device Designation for speech restoration. Synchron’s Stentrode lets users control consumer devices from neural signals. Both are in trials, with limited commercial availability projected around 2028 to 2030. Augmentation of healthy individuals remains a separate, unresolved question.

Where can Florida physicians get involved in shaping AI policy?

Start with the Florida Medical Association, which coordinates physician advocacy at the state level, and join The Atlas Accord, the physician-led alliance working to keep doctors leading the decisions that reshape their profession. Push for clinician representation on technology procurement at your hospital or practice, and engage early with consent and liability questions before adopting ambient documentation tools.

Hero image: illustration created with AI image tools.